Summit Therapeutics PLC (SMMT) — Financial Flexibility Index
Summit Therapeutics PLC (SMMT) has a Financial Flexibility Index of -1.37x as of June 2026. Free cash flow of $-166.81 Million (operating CF $-167.78 Million minus capex $968.20K) represents -1% of total liabilities ($122.20 Million). Check Summit Therapeutics PLC (SMMT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Summit Therapeutics PLC Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Summit Therapeutics PLC across 23 annual periods. For the full cash flow conversion analysis, see Summit Therapeutics PLC (SMMT) cash conversion ratio.
Annual Financial Flexibility Index for Summit Therapeutics PLC (2003–2025)
Year-by-year free cash flow to debt coverage for Summit Therapeutics PLC. Explore Summit Therapeutics PLC (SMMT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.49x | $-239.18 Million | $-239.67 Million | $68.52 Million | ▼ -15.1% |
| 2024 | -3.03x | $-113.44 Million | $-113.56 Million | $37.41 Million | ▼ -395.7% |
| 2023 | -0.61x | $-60.64 Million | $-60.74 Million | $99.12 Million | ▼ -702.9% |
| 2022 | -0.08x | $-33.39 Million | $-33.90 Million | $438.18 Million | ▲ +96.8% |
| 2021 | -2.40x | $-53.58 Million | $-53.81 Million | $22.30 Million | ▼ -16.1% |
| 2020 | -2.07x | $-35.03 Million | $-35.34 Million | $16.93 Million | ▼ -12.4% |
| 2019 | -1.84x | $-26.40 Million | $-26.66 Million | $14.34 Million | ▼ -25.0% |
| 2018 | -1.47x | $-34.94 Million | $-35.11 Million | $23.74 Million | ▼ -361.6% |
| 2017 | -0.32x | $-19.90 Million | $-20.58 Million | $62.40 Million | ▼ -207.1% |
| 2016 | 0.30x | $15.29 Million | $15.18 Million | $51.35 Million | ▲ +106.9% |
| 2015 | -4.34x | $-24.38 Million | $-24.47 Million | $5.62 Million | ▼ -154.5% |
| 2014 | -1.71x | $-16.53 Million | $-16.59 Million | $9.69 Million | ▲ +25.8% |
| 2013 | -2.30x | $-9.60 Million | $-9.68 Million | $4.18 Million | ▼ -12.7% |
| 2012 | -2.04x | $-4.91 Million | $-5.03 Million | $2.41 Million | ▼ -32.1% |
| 2011 | -1.54x | $-3.61 Million | $-3.80 Million | $2.34 Million | ▲ +16.7% |
| 2010 | -1.85x | $-4.14 Million | $-4.34 Million | $2.24 Million | ▼ -281.2% |
| 2009 | -0.49x | $-2.51 Million | $-2.65 Million | $5.15 Million | ▲ +71.1% |
| 2008 | -1.68x | $-13.07 Million | $-14.72 Million | $7.77 Million | ▼ -109.9% |
| 2007 | -0.80x | $-12.26 Million | $-16.13 Million | $15.30 Million | ▼ -96.0% |
| 2006 | -0.41x | $-2.59 Million | $-5.96 Million | $6.33 Million | ▼ -167.0% |
| 2005 | 0.61x | $1.52 Million | $-931.84K | $2.49 Million | ▲ +398.0% |
| 2004 | 0.12x | $42.92K | $29.74K | $350.21K | ▲ +100.8% |
| 2003 | -14.71x | $-53.68K | $-64.97K | $3.65K | — |